ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies.
Ramon Alfredo C. Siochi, PhD, DABR, FAAPM is the Associate Chair and the Director of Medical Physics of the Department of Radiation Oncology at West Virginia University Medicine was selected to give an oral presentation: Improving Interconnectivity and Intra operability in radiation oncology; IHE-RO Initiative.
Integrating Healthcare Enterprise - Radiation Oncology (IHE-RO) is an initiative that helps to ensure a safe, efficient radiation oncology practice by improving system to system connections. With technology at the core of delivering care in radiation oncology, it is imperative that patient safety is not compromised. Integrating Healthcare Enterprise - Radiation Oncology (IHE-RO) is an initiative that helps to ensure a safe, efficient radiation oncology practice by improving system to system connections.
WVU faculty and residents presented the following posters:
Influence of dexamethasone premedication on acute lung toxicity in lung SBRT. F Alite, MP Shaikh, MJ Greenberg, D Christie, A Rostock, U Malik, A Mahadevan
Patterns of relapse after salvage autologous hematopoietic cell transplantation for Hodgkin’s lymphoma: should site of relapse relative to initially involved sites be used to guide indications for peritransplant radiation therapy. JC Farris, A Ritter, MD Craig, N Shah, L Veltri, A Kanate, K Ross, J A Vargo
Radiation associated hypertension in patients undergoing prostate irradiation. Farrugia M, Bianco C, Sambamoorthi U, Mattes M
Tumor cavity recurrence after stereotactic radiosurgery of surgically resected brain metastases: Implication of deviation from contouring guidelines. D McDermott, J Hack, C Cifarelli, JA Vargo
Predictors of local control and symptomatic pneumonitis after lung SBRT. S Parker, LM Schmidt, S Wen, MD Mattes
The lack of consensus of international contouring guidelines for the dorsal border of the chest wall clinical target volume: What is the impact on organs at risk and relationships in the modern era? P Pifer, R Bice, GM Jacobson, K Lupinacci, S Beriwal, H Hazard, JA Vargo
Dr. Hannah Hazard-Jenkins, right, examines a patient at WVU’s Mary Babb Randolph Cancer Center. Hazard-Jenkins is an advocate for the Norma Mae Huggins Cancer Research Endowment Fund, which provides support for clinical research trials at the WVU Cancer Institute. (WVU Photo)
Submissions sought for Robert E. Stitzel Award for Student-Generated Educational Media in Pharmacology
The Stitzel Award Competition is soliciting submissions of pharmacology educational media from students in any health professional or graduate program within the WVU Health Sciences Center.
The WVU Cancer Institute has enrolled two of the first three patients in a national clinical trial for a novel breast cancer vaccine.